Pharma major GSK (LSE: GSK) has been caught up in a wave of industrial action hitting British companies, as the UK struggles with stubbornly high inflation and a rising cost of living.
750 workers at six different GSK locations, all members of the Unite union, will hold a series of strikes over the course of next month.
The action comes after union bosses rejected the company’s offer of a 6% pay increase and a one-time payment of £1,300 ($1,600), with national officer Tony Devlin saying GSK had “effectively stuck two fingers up to its workforce by walking away from the pay negotiations.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze